Bio-Rad to sell $200 million notes to fund tender

By Paul A. Harris

St. Louis, July 17 - Bio-Rad Laboratories, Inc. announced on Thursday that it will offer $200 million of senior subordinated notes.

Proceeds from the Rule 144A/Regulation S offering will be used to fund the company's tender for $88.715 million of senior subordinated notes due 2007. Goldman Sachs & Co. is dealer-manager of the tender. The consent date is July 30, 2003.

Timing, maturity and structure remain to be determined, according to an informed source, who declined to specify the make-up of the syndicate.

The issuer is a Hercules, Calif.-based manufacturer and distributor of life science research products and clinical diagnostics.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.